[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335459-105":59,"doc-detail-335459-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-cell-analysis-of-tumor-microenvironment-and-cell-adhesion-reveals-that-interleukin-1-beta-promotes-cancer-cell-proliferation-in-breast-cancer","Single-cell analysis of tumor microenvironment and cell adhesion reveals that interleukin-1 beta promotes cancer cell proliferation in breast cancer","","Background: Triple-negative breast cancer (TNBC), defined by lack of ER, PR, and HER2, represents 10%–15% of breast cancers, with high tumor microenvironment heterogeneity; the controlling role of plasma cells in TNBC migration remains unclear. Methods: Single-cell RNA sequencing was analyzed across five HER2+ , 12 ER+/PR+ , and nine TNBC samples, with potential targets validated by immunohistochemistry. Results: Plasma cells were enriched in TNBC, interacting with T cells via the intercellular adhesion molecule 2–integrin–aLb2 complex to release IL1B, promoting tumor growth. Conclusion: Plasma cells support TNBC progression and IL1B functions as a new prognostic marker.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-analysis-of-tumor-microenvironment-and-cell-adhesion-reveals-that-interleukin-1-beta-promotes-cancer-cell-proliferation-in-breast-cancer/335459/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-analysis-of-tumor-microenvironment-and-cell-adhesion-reveals-that-interleukin-1-beta-promotes-cancer-cell-proliferation-in-breast-cancer/335459.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research question about TNBC and plasma cells?","Question",{"text":112,"@type":113},"The study investigates how plasma cells control tumor migration progression in triple-negative breast cancer, which is not fully understood.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the single-cell and validation experiments performed?",{"text":117,"@type":113},"Single-cell RNA sequencing data from 26 breast cancer samples were analyzed, and potential targets identified from the analyses were validated using immunohistochemistry.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links plasma cells to tumor growth in TNBC?",{"text":121,"@type":113},"Cell communication analysis suggests plasma cells interact with T cells via the intercellular adhesion molecule 2–integrin–aLb2 complex, leading to IL1B release that promotes tumor growth.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335459,1790496335,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10. 1002/ame2 .12445  \nOR I G I NAL ART I C L E  \nSingle-cell analysis of tumor microenvironment and cell adhesion reveals that interleukin-1 beta promotes cancer cell proliferation in breast cancer  \nWenyan Wang1 | Gehong Dong2 | Ziguo Yang1 | Shaoxiang Li2 | Jia Li2 | Lin Wang1 | Qiang Zhu1 | Yuchen Wang3   \n1Department of General Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China  \n2Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China  \n3 Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China  \nCorrespondence  \nYuchen Wang, Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Xian Nong Tan Street, Xicheng, Beijing 100050, China. [Email:](Email: wangyuchen@imm.ac.cn)[ wangyuchen@imm.ac.cn](Email: wangyuchen@imm.ac.cn)  \nFunding information  \nYoung Elite Scientists Sponsorship Program by Beijing Association for science and technology, Grant/Award Number: BYESS2023226  \nAbstract  \nBackground: Triple-negative breast cancer (TNBC), which is so called because of the lack of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) receptors on the cancer cells, accounts for 10%– 15% of all breast cancers. The heterogeneity of the tumor microenvironment is high. However, the role of plasma cells controlling the tumor migration progression in TNBC is still not fully understood.  \nMethods: We analyzed single-cell RNA sequencing data from five HER2 positive, 12 ER positive/PR positive, and nine TNBC samples. The potential targets were validated by immunohistochemistry.  \nResults: Plasma cells were enriched in TNBC samples, which was consistent with validation using data from The Cancer Genome Atlas. Cell communication analysis revealed that plasma cells interact with T cells through the intercellular adhesion molecule 2–integrin–aLb2 complex, and then release interleukin 1 beta (IL1B), as verified by immunohistochemistry, ultimately promoting tumor growth.  \nConclusion: Our results revealed the role of plasma cells in TNBC and identified IL1Bas a new prognostic marker for TNBC.  \nK E Y WO R D S  \nbiomaterial, breast cancer, IL1B, plasma cells, scRNA-seq  \n1 | INTRODUCTION  \nBreast cancer is one of the most common carcinomas in women, and 2.3 million new cases of breast cancer were reported in 2020 worldwide, accounting for one quarter of all cancer cases.1,2 The main pathogenic types of breast cancer include estrogen receptor positive/progesterone receptor positive (ER+/PR+), human epidermal growth factor receptor-2 positive (HER2+), and triple-negative  \nbreast cancer (TNBC) subtypes based on their pathological immunohistochemistry (IHC) characteristics.3 The prognosis for subtypes varies greatly and most TNBC has a higher probability of metastasis and poorer prognosis than other subtypes due to limited effective therapy strategies.4 Because the intratumoral heterogeneity of breast cancer is the main cause of drug resistance to tumor therapy,5,6 it is important to investigate new biomarkers for TNBC to provide new treatment targets.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2024 The Author(s) . Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.  \nSingle-cell RNA sequencing (scRNA-seq) is a powerful tool that provides the expression profile of individual cells, identifies cell subpopulations by nonlinear dimension reduction and cell markers, and compares subtypes in cell populations.7,8 Insights into the hetero","cbCaicMTOe539IDA","https://ap.wps.com/l/cbCaicMTOe539IDA","pdf",8045119,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Breast cancer subtypes and TNBC prognosis\n## Tumor heterogeneity and biomarker need\n# Methods\n## Data processing and tissue specimens\n## scRNAseq data processing and clustering","[{\"question\":\"What is the main research question about TNBC and plasma cells?\",\"answer\":\"The study investigates how plasma cells control tumor migration progression in triple-negative breast cancer, which is not fully understood.\"},{\"question\":\"How were the single-cell and validation experiments performed?\",\"answer\":\"Single-cell RNA sequencing data from 26 breast cancer samples were analyzed, and potential targets identified from the analyses were validated using immunohistochemistry.\"},{\"question\":\"What mechanism links plasma cells to tumor growth in TNBC?\",\"answer\":\"Cell communication analysis suggests plasma cells interact with T cells via the intercellular adhesion molecule 2–integrin–aLb2 complex, leading to IL1B release that promotes tumor growth.\"}]","Single-cell analysis of tumor microenvironment and cell adhesion reveals that interleukin-1 beta promotes cancer cell proliferation in breast cancer | PDF",1790011055,23]